Plasma selenium levels associated with subsequent risk of prostate cancer

American Journal of Urology Review

Volumn 3, Issue 1, 2005, Pages 28-34

  Li, Haojie ^a   Stampfer, Meir J ^a,b   Giovannucci, Edward L ^a,b   Morris, J Steven ^c   Willett, Walter C ^a,b   Gaziano, J Michael ^a   Ma, Jing ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SELENIUM;

ADULT; ADVANCED CANCER; AGED; BLOOD ANALYSIS; BLOOD LEVEL; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PROSTATE CANCER; QUESTIONNAIRE; REVIEW; SCREENING TEST; SMOKING HABIT; STUDENT T TEST; SURVIVAL RATE; TUMOR GROWTH;

EID: 14744301224     PISSN: 15428745     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000;85:60-67.
2. Hsing AW, Devesa SS. Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev. 2001;23:3-13.
3. Breslow N, Chan CW, Dhom G, et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer. 1977;20:680-688.
4. Griffin AC. The chemoprevention role of selenium carcinogenesis. In: Arnott MS, ed. Molecular Interrelations of Nutrition and Cancer. New York, NY: Raven Press; 1982:401-408.
5. Webber MM, Perez-Ripoll EA, James GT. Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro. Biochem Biophys Res Commun. 1985;130:603-609.
6. Redman C, Scott JA, Baines AT, et al. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett. 1998;125:103-110.
7. Redman C, Xu MJ, Peng YM, et al. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis. 1997;18:1195-1202.
8. Griffin AC. Role of selenium in the chemoprevention of cancer. Adv Cancer Res. 1979;29:419-442.
9. Waters DJ, Shen S, Cooley DM, et al. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst. 2003;95: 237-241.
10. Shamberger RJ, Willis CE. Selenium distribution and human cancer mortality. CRC Crit Rev Clin Lab Sci. 1971;2:211-221.
11. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in US counties. Arch Environ Health. 1991;46:37-42.
12. Yoshizawa K, Willett WC, Morris JS, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998; 90:1219-1224.
13. van den Brandt PA, Zeegers MP, Bode P, et al. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2003;12:866-871.
14. Nomura AM, Lee J, Stemmermann GN, et al. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:883-887.
15. Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol. 2001;166:2034-2038.
16. Helzlsouer KJ, Huang M Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000;92:2018-2023.
17. Goodman GE, Schaffer S, Bankson DD, et al. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:1069-1076.
18. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957-1963.
19. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol. 1998;81:730-734.
20. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002;11:630-639.
21. Stephenson RA. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database. Urol Clin North Am. 2002;29:173-181.
22. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med. 1989;321:129-135.
23. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
24. Gann PH, Aennekens CH, Ma J, et al. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst. 1996;88:1118-1126.
25. Catalona WJ, Avioli LV. Diagnosis, staging, and surgical treatment of prostatic carcinoma. Arch Intern Med. 1987;147:361-363.
26. McKnown DM, Morris JS. Rapid measurement of selenium in biological samples using instrumental neutron activation analysis. J Radioanalytic Chemistry. 1978;43: 411-420.
27. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 1995;273:289-294.
28. Gann PH, Ma J, Catalona WJ, et al. Strategies combining total and percent-free prostate specific antigen for detecting prostate cancer: a prospective evaluation. J Urol. 2002;167:2427-2434.
29. Longnecker MP, Stram DO, Taylor PR, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology. 1996;7:384-390.
30. Klein EA, Lippman SM, Thompson IM, et al. The selenium and vitamin E cancer prevention trial. World J Urol. 2003;21:21-27.